Literature DB >> 17302891

Accelerated in vitro differentiation of blood monocytes into dendritic cells in human sepsis.

V Faivre1, A-C Lukaszewicz, A Alves, D Charron, D Payen, A Haziot.   

Abstract

Summary Sepsis-induced immune depression is characterized by infection susceptibility and monocyte early deactivation. Because monocytes are precursors for dendritic cells (DC), alterations in their differentiation into DC may contribute to defective immune responses in septic patients. We therefore investigated the ability of monocytes to differentiate into functional DC in vitro in patients undergoing surgery for peritonitis. Monocytes from 20 patients collected immediately after surgery (D0), at week 1 and at weeks 3-4 and from 11 control donors were differentiated into immature DC. We determined the phenotype of monocytes and derived DC, and analysed the ability of DC to respond to microbial products and to elicit T cell responses in a mixed leucocyte reaction (MLR). We show that, although monocytes from septic patients were deactivated with decreased responses to lipopolysaccharide (LPS) and peptidoglycan and low human leucocyte antigen D-related (HLA-DR) expression, they expressed the co-stimulatory molecule CD80, CD40 and CCR7. Monocytes collected from patients at D0 and week 1 differentiated faster into DC with early loss of CD14 expression. Expression of HLA-DR increased dramatically in culture to reach control levels, as did responses of DC to LPS and peptidoglycan. However, although patient and control immature DC had similar abilities to induce T cell proliferation in MLR, maturation of DC derived from patients did not increase T cell responses. These results show that circulating monocytes from septic patients express markers of activation and/or differentiation despite functional deactivation, and differentiate rapidly into phenotypically normal DC. These DC fail, however, to increase their T cell activation abilities upon maturation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302891      PMCID: PMC1810505          DOI: 10.1111/j.1365-2249.2006.03287.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  62 in total

1.  IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals.

Authors:  Kathleen F Nolan; Victoria Strong; Dulce Soler; Paul J Fairchild; Stephen P Cobbold; Ruth Croxton; Jose-Angel Gonzalo; Ana Rubio; Meghan Wells; Herman Waldmann
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  TNF skews monocyte differentiation from macrophages to dendritic cells.

Authors:  Pascale Chomarat; Carole Dantin; Lynda Bennett; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

3.  Differentiation of human alloreactive CD4+ and CD8+ T cells in vitro.

Authors:  Natalia Nikolaeva; Elena Uss; Ester M M van Leeuwen; René A W van Lier; Ineke J M ten Berge
Journal:  Transplantation       Date:  2004-09-27       Impact factor: 4.939

Review 4.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

5.  The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Authors:  Guillaume Monneret; Marie-Emmanuelle Finck; Fabienne Venet; Anne-Lise Debard; Julien Bohé; Jacques Bienvenu; Alain Lepape
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

6.  Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis.

Authors:  Philip A Efron; Antonio Martins; Douglas Minnich; Kevin Tinsley; Ricardo Ungaro; Frances R Bahjat; Richard Hotchkiss; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.

Authors:  Jacqueline E Calvano; Doreen M Agnese; John Y Um; Masahiro Goshima; Ritu Singhal; Susette M Coyle; Michael T Reddell; Ashwini Kumar; Steve E Calvano; Stephen F Lowry
Journal:  Shock       Date:  2003-11       Impact factor: 3.454

9.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

Authors:  C Brun-Buisson; P Meshaka; P Pinton; B Vallet
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

10.  Transient leukocytosis, granulocyte colony-stimulating factor plasma concentrations, and apoptosis determined by binding of annexin V by peripheral leukocytes in patients with severe sepsis.

Authors:  Manfred Weiss; Mohammed Elsharkawi; Katrin Welt; Elisabeth-Marion Schneider
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

View more
  21 in total

Review 1.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

2.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

Review 3.  [Epigenetic regulation in sepsis : current state of knowledge].

Authors:  S Weiterer; F Uhle; B H Siegler; C Lichtenstern; M Bartkuhn; M A Weigand
Journal:  Anaesthesist       Date:  2015-01       Impact factor: 1.041

Review 4.  The importance of a sepsis layered early warning system for critical patients.

Authors:  Hui Lian; Hongmin Zhang; Xin Ding; Xiaoting Wang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation.

Authors:  Lei Lei; Ying Xiong; Jia Chen; Jin-Bo Yang; Yi Wang; Xin-Ying Yang; Catherine C Y Chang; Bao-Liang Song; Ta-Yuan Chang; Bo-Liang Li
Journal:  J Lipid Res       Date:  2009-02-02       Impact factor: 5.922

Review 6.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

7.  Acute lung injury but not sepsis is associated with increased colony formation by peripheral blood mononuclear cells.

Authors:  Ellen L Burnham; Meredith Mealer; Jeanette Gaydos; Susan Majka; Marc Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-20       Impact factor: 6.914

8.  Leukocyte phenotyping to stratify septic shock patients.

Authors:  Jonathan E McDunn; Richard S Hotchkiss
Journal:  Crit Care       Date:  2009-04-03       Impact factor: 9.097

Review 9.  Alterations of dendritic cells in sepsis: featured role in immunoparalysis.

Authors:  Xia Fan; Zheng Liu; He Jin; Jun Yan; Hua-ping Liang
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

10.  Human monocytes differentiate into dendritic cells subsets that induce anergic and regulatory T cells in sepsis.

Authors:  Valérie Faivre; Anne Claire Lukaszewicz; Arnaud Alves; Dominique Charron; Didier Payen; Alain Haziot
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.